使用数据到护理策略来优化康涅狄格州的HIV护理连续性:随机对照试验的结果
Eteri Machavariani1, Janet Miceli1, Frederick L Altice1,2
1Department of Internal Medicine, Section of Infectious Disease, HIV/AIDS Program, Yale University School of Medicine, New Haven, CT.
Journal of acquired immune deficiency syndromes (1999)
|February 7, 2024
概括
数据到护理 (D2C) 显著改善了艾滋病毒患者在护理之外的重新参与. 早期重新接触对病毒的保留和病毒抑制产生了积极的影响,突出显示了D2C.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 临床医学 临床医学
背景情况:
- 重新接触那些没有接受护理的艾滋病毒感染者是一个持续的挑战.
- 数据转化为护理 (D2C) 是重新参与的有希望的战略.
- 需要有效的策略来改善艾滋病毒治疗连续性的结果.
研究的目的:
- 与标准护理相比,使用疾病干预专家 (DIS) 评估D2C策略的有效性.
- 评估D2C对重新参与,在护理中的保留和病毒抑制的影响.
- 确定预测艾滋病毒治疗连续性成功的因素.
主要方法:
- 在康涅狄格州的23家艾滋病毒诊所进行了一项前性随机对照试验.
- 655名新出院的参与者被随机分配到DIS或标准护理的D2C策略中.
- 用多变量回归分析了艾滋病毒治疗连续结果,包括90天的重新参与,12个月的保留和病毒抑制.
主要成果:
- D2C策略显著增加了90天后的重新参与 (aOR = 1.42,P = 0.045).
- 预测90天重新参与的预测因素包括40岁以上的年龄和围产期艾滋病毒风险.
- 90天后重新接触是12个月保留和病毒抑制的强有力的预测因素.
结论:
- 一个D2C策略有效地提高了艾滋病毒感染者不在护理中的重新参与率.
- 早期重新参与至关重要,以实现下游的好处,如保留和病毒抑制.
- 识别预测因素可以进一步优化D2C干预措施,以改善艾滋病毒治疗连续结果.
相关概念视频
01:15Methods of Documentation VI: Case Management Model
573
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
573
01:16Crossover Experiments
2.8K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.8K
01:25Strategies for Assessing and Addressing Confounding
101
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
101
01:10Retrovirus Life Cycles
46.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.0K
01:16Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K